Dirk Eberhard

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Marcus Bantscheff, Dirk Eberhard, Yann Abraham et al. · Nature Biotechnology · 2007 · 1K citations

Quantitative Chemical Proteomics, Biochemistry, Medicine +9

A physical and functional map of the human TNF-α/NF-κB signal transduction pathway

Tewis Bouwmeester, Angela Bauch, Heinz Ruffner et al. · Nature Cell Biology · 2004 · 1K citations

Inflammation, Transcriptional Regulation, Molecular Physiology +14

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

Laurens Kruidenier, Chun‐wa Chung, Zhongjun Cheng et al. · Nature · 2012 · 932 citations · Full text

Inflammation, Cytokine, Inflammatory Disease +12

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

Huw D. Lewis, John Liddle, Jim Coote et al. · Nature Chemical Biology · 2015 · 717 citations · Full text

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Marcus Bantscheff, Carsten Hopf, Mikhail M. Savitski et al. · Nature Biotechnology · 2011 · 661 citations

Chemoproteomics Profiling, Molecular Characterization, Drug Target +10